28.10.2014 11:47:00

Citi Appointed Depositary Bank for DBV Technologies’ ADR Programme

Citi’s (NYSE symbol: C) Issuer Services business, acting through Citibank N.A., has been appointed by DBV TECHNOLOGIES S.A. ("DBV Technologies”), a clinical-stage specialty biopharmaceutical company as depositary bank for their NASDAQ listed American Depositary Receipt (ADR) programme. DBV Technologies American Depositary Shares are listed on NASDAQ Global Select Market under symbol "DBVT”. The underlying ordinary shares are listed on Euronext Paris and trade under symbol "DBV”.

David Schilansky, Chief Financial Officer at DBV Technologies commented "we are excited about being more visible in the US and having direct access to US investors through our NASDAQ listing. We look forward to working closely with Citi and leveraging their institutional investor and broker relationships to develop our US shareholder base further.”

"Citi is delighted to be appointed by DBV Technologies as depositary bank for their US listing,” Dirk Jones, Global Head of Issuer Services said, "we are confident that we will be able to assist DBV Technologies in expanding their investor outreach through the support of our Investor Relations Advisory team and our unparalleled equity distribution network.”

For more information on Citi’s Depositary Receipt Services, visit www.citi.com/dr.

About DBV Technologies

DBV Technologies is developing Viaskin®, an innovative new approach to the treatment of allergies - a major public health issue that has been increasing in prevalence. DBV Technologies, incorporated in France in 2002, has developed a proprietary, worldwide-patented technology for administering an allergen to intact skin while avoiding transfer to the blood, and thus considerably lowering the risk of a systemic, allergic reaction in the event of accidental exposure.

DBV Technologies ordinary shares are traded on segment C of Euronext Paris (Ticker: DBV, ISIN code: FR0010417345).

DBV Technologies American Depositary Shares are listed on NASDAQ Global Select Market (Ticker: DBVT).

About Citi

Citi, the leading global financial services company, has approximately 200 million customer accounts and does business in more than 160 countries and jurisdictions. Citi provides consumers, corporations, governments and institutions with a broad range of financial products and services, including consumer banking and credit, corporate and investment banking, securities brokerage, transaction services, and wealth management.

Additional information may be found at www.citigroup.com | Twitter: @Citi | YouTube: www.youtube.com/citi | Blog: http://new.citi.com | Facebook: www.facebook.com/citi | LinkedIn: www.linkedin.com/company/citi

Nachrichten zu DBV TECHNOLOGIESmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu DBV TECHNOLOGIESmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

DBV TECHNOLOGIES 0,75 1,35% DBV TECHNOLOGIES